Following a TRAIL: update on a ligand and its five receptors (Q28292767)

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Identification and characterization of a new member of the TNF family that induces apoptosis

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

The receptor for the cytotoxic ligand TRAIL

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Interaction of DAP3 and FADD only after cellular disruption

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha- and Fas-induced cell death

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CR.7290236

IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Enhanced and accelerated lymphoproliferation in Fas-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Activation-induced cell death in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

T cell-specific FADD-deficient mice: FADD is required for early T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

A role for FADD in T cell activation and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Normal thymocyte negative selection in TRAIL-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infecti

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

TRAIL/Apo-2 ligand induces primary plasma cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Reovirus-induced apoptosis is mediated by TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

The TNF and TNF receptor superfamilies: integrating mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Inactivating mutations of KILLER/DR5 gene in gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Biological significance and molecular mechanisms of p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

GPI-microdomains: a role in signalling via immunoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

JNK/SAPK activity contributes to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Bisindolylmaleimide VIII enhances DR5-mediated apoptosis through the MKK4/JNK/p38 kinase and the mitochondrial pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

TRAIL regulates normal erythroid maturation through an ERK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Caspase activation: the induced-proximity model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Critical roles of TRAIL in hepatic cell death and hepatic inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

KILLER/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Fas modulation of apoptosis during negative selection of thymocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

The suicide in the thymus, a twisted trail

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

TRAIL/Apo-2-ligand-induced apoptosis in human T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

TRAIL: a mechanism of tumor surveillance in an immune privileged site

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

The interplay between the Bcl-2 family and death receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7290236

7 January 2021

Identifiers

DOI

10.1038/SJ.CR.7290236

1 reference

Consolidated OpenCitations Corpus – April 2017

release_6otzzg7kibdx3cxzmb3r3o5xoe

4005973

Fatcat ID

0 references

4005973

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference